• ქართული
  • English
  • Drugmaker Sanofi expects further profit growth from narrowed focus

    French drugmaker Sanofi on Thursday forecast further profit growth for 2020 even as it drops some research in areas such as diabetes in a shake-up to narrow its focus on blockbuster treatments including eczema medicine Dupixent.

    Market Quotes by TradingView